z-logo
open-access-imgOpen Access
Intrahepatic Sarcomatoid Cholangiocarcinoma
Author(s) -
Shalini Malhotra,
Joanna Wood,
T. Mansy,
Rajeev Singh,
Abed Zaitoun,
Srinivasan Madhusudan
Publication year - 2010
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2010/701476
Subject(s) - medicine , intrahepatic cholangiocarcinoma , gemcitabine , sarcomatoid carcinoma , chemotherapy , rare disease , cisplatin , immunohistochemistry , disease , oncology , radiology , gastroenterology
Intrahepatic sarcomatoid cholangiocarcinoma is a rare but an aggressive variant of cholangiocarcinoma with a very poor prognosis. We report the first caucasian patient who presented with a rapidly enlarging liver mass requiring hepatic resection. Detailed histopathological analyses including immunohistochemistry and electron microscopy confirmed sarcomatoid cholangiocarcinoma. The patient had early onset disease recurrence within 5 weeks of surgery. Here we demonstrate that combination chemotherapy with gemcitabine and cisplatin is a potential treatment option in patients with advanced sarcomatous cholangiocarcinoma. The patient achieved sustained partial remission with combination chemotherapy and remains alive and well more than 29 months since initial surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom